Holen Sie sich die Stockscreener-App
3.96
0.25%
-0.01
Handel nachbörslich:
4.10
0.14
+3.54%
Orasure Technologies Inc Aktie (OSUR) Neueste Nachrichten
OraSure Technologies Inc (OSUR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OraSure Technologies Inc (OSUR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OSUR|OraSure Technologies Inc|Price:3.800| - TradingKey
OSUR|OraSure Technologies Inc|Price:3.970|Chg%:-0.060 - TradingKey
OraSure Technologies Inc (OSUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OraSure Technologies Inc (OSUR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
OraSure Technologies, Inc. Revenue Breakdown – LSX:881351 - TradingView
OraSure Technologies, Inc. Revenue Breakdown – TRADEGATE:EP3 - TradingView
3 Promising Penny Stocks With Market Caps Over $60M - simplywall.st
OraSure Technologies Inc (OSUR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enterprise value to revenue forward of OraSure Technologies, Inc. – NASDAQ:OSUR - TradingView
OraSure to announce Q2 2026 financial results on August 5 - scanx.trade
OraSure Technologies, Inc. (OSUR) stock price, news, quote and history - Yahoo Finance Singapore
OraSure's Q2 results webcast is set for Aug. 5 after market close - Stock Titan
OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th - Moomoo
Bethlehem’s OraSure gets FDA emergency authorization for Ebola test - Lehigh Valley Business
OraSure wins FDA emergency nod for Ebola test (OSUR:NASDAQ) - Seeking Alpha
OraSure receives Emergency Use Authorization for second generation Ebola test - WFMZ.com
AT&T, Cal-Maine Foods, OraSure Technologies - TradingView
Why Has OraSure Technologies (NASDAQ:OSUR) Entered Nasdaq News? - Kalkine Media
OraSure (OSUR) Secures FDA Approval for Enhanced Ebola Rapid Tes - GuruFocus
OraSure Technologies Gets Emergency Use Authorization From FDA for New Ebola Test - marketscreener.com
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test - The Manila Times
Enterprise value to revenue forward of OraSure Technologies, Inc. – MUN:EP3 - TradingView
OraSure Technologies (OSUR) Dips Below $3.90 as Selling Pressure MountsThematic ETF Flow - dars.gov.et
OraSure Technologies (OSUR) Slides 6.8% as Shares Test Critical Support Near $3.76Single Stock ETF - dars.gov.et
OraSure Technologies (OSUR) Slides 6.8% as Key Support Level Comes into FocusAI Trade Signals - dars.gov.et
Bethlehem's OraSure puts another property up for sale - WFMZ.com
OraSure Technologies stock holds steady as diagnostics business targets growth - AD HOC NEWS
OraSure Technologies updates highlight diagnostics focus amid shifting health trends - ad-hoc-news.de
OSUR Q1 2026 Earnings: Significant Earnings Miss as Losses WidenSaaS Earnings Trends - DonanımHaber
OSUROrasure Technologies Inc Latest SEC Filings - Finviz
Form 4 OraSure Technologies Inc For: 30 June By Investing.com - Investing.com Nigeria
OraSure Technologies (OSUR) director takes 3,666-share stock grant in lieu of cash - Stock Titan
Enterprise value to EBIT forward of OraSure Technologies, Inc. – MUN:EP3 - TradingView
Price to earnings forward of OraSure Technologies, Inc. – NASDAQ:OSUR - TradingView
Price to book forward of OraSure Technologies, Inc. – NASDAQ:OSUR - TradingView
Price to book forward of OraSure Technologies, Inc. – LSX:881351 - TradingView
Price to sales forward of OraSure Technologies, Inc. – NASDAQ:OSUR - TradingView
Price to sales forward of OraSure Technologies, Inc. – LSX:881351 - TradingView
Enterprise value to revenue forward of OraSure Technologies, Inc. – LSX:881351 - TradingView
Price to earnings forward of OraSure Technologies, Inc. – LSX:881351 - TradingView
Enterprise value to EBITDA forward of OraSure Technologies, Inc. – LSX:881351 - TradingView
OraSure Technologies Q1 2026 Earnings: EPS Misses Estimates as Stock Declines Over 4.9%Quarterly Earnings - DonanımHaber
OraSure gets FDA nod for at-home STI urine collection kit - Investing.com Nigeria
3 Promising Penny Stocks With At Least $200M Market Cap - simplywall.st
OraSure Technologies Hits New 52-Week High of $4.36, Marking Significant Growth - MarketsMojo
OraSure Technologies Inc (OSUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OraSure Technologies Inc (OSUR) Institutional Confidence - TradingKey
OraSure Technologies Inc (OSUR) Valuation: PE, PB & Fair Value Analysis - TradingKey
OraSure Technologies Inc (OSUR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OraSure Wins FDA Clearance for At-Home STI Collection - The Globe and Mail
OraSure receives FDA clearance for home urine collection kit for STIs - Lehigh Valley Business
Is Taysha Gene Therapies, Inc. (TSHA) A Good Stock To Buy Now? - Yahoo Finance
FDA Clears Home Urine Collection Kit for STI Testing - Conexiant
OraSure secures FDA clearance for product seen as key to future growth - WFMZ.com
OraSure stock jumps on FDA clearance for at-home STI kit - Investing.com
OraSure stock jumps on FDA clearance for at-home STI kit By Investing.com - Investing.com South Africa
0.62%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):